Understanding the Perspective of Youths on Undergoing Metabolic Monitoring While on Second-Generation Antipsychotics: Challenges, Insight, and Implications

被引:0
|
作者
Aouira, Nisreen [1 ,7 ]
Khan, Sohil [1 ,2 ,3 ,4 ]
Heussler, Helen [2 ,5 ]
Haywood, Alison [1 ,2 ]
Karaksha, Abdullah [1 ]
Bor, William [2 ,5 ,6 ]
机构
[1] Griffith Univ, Menzies Hlth Inst Queensland, Sch Pharm & Med Sci, Gold Coast, Australia
[2] Univ Queensland, Mater Res Inst, Brisbane, Australia
[3] Prasanna Inst Publ Hlth, Manipal, India
[4] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Manipal, India
[5] Childrens Hlth Queensland Hosp & Hlth Serv, Brisbane, Australia
[6] Queensland Hlth, Ctr Childrens Hlth Res, Child & Youth Mental Hlth Serv, Brisbane, Australia
[7] Griffith Univ, Menzies Hlth Inst Queensland, Sch Pharm & Med Sci, Gold Coast 4222, Australia
关键词
youths; perspective; antipsychotics; barriers; suggestions; health; PSYCHOTROPIC MEDICATION; PHYSICAL-ACTIVITY; EXPERIENCE; BARRIERS; DEPRESSION; ADOLESCENTS; CHILDREN; CARE; PARTICIPATION; PERCEPTIONS;
D O I
10.1089/cap.2023.0016
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: Prescription of second-generation antipsychotics (SGAs) in youths is rapidly increasing globally, despite the potential for significant adverse effects and long-term health consequences. A known adverse reaction resulting from SGAs is metabolic syndrome (MS). Youths exposed to antipsychotics are at higher risk than adults for adverse drug reactions, including adverse events such as MS (with weight gain as the most significant adverse outcome) and other long-term endocrinological abnormalities. This study aimed to explore the experiences of young patients on factors impacting barriers to metabolic monitoring of SGAs and the strategies to address those barriers thereby providing further guidance on policy and service delivery.Methods: Semi-structured interviews were conducted with patients (youths who were prescribed SGAs) who attended Child and Youth Mental Health Services. The interviews focused on barriers to monitoring and strategies to enhance rates of monitoring that could be customized across study sites.Results: Young patients revealed that none of them had any concerns or objections to receiving anthropometric metabolic measurements. However, they seemed concerned to undergo blood tests as part of the metabolic monitoring process. Specifically, youths cited their fear of the needles as barrier to undergo the required blood tests. Youths have also reported that their dislike to healthy foods and exercise being the most common challenge they face while trying to engage in a healthy lifestyle to manage the SGAs resulted weight gain.Conclusion: Prescribers are recommended to actively engage young patients about the expected SGAs-induced adverse effects, the importance of conducting metabolic monitoring, and how to prevent and minimize the expected adverse effects from the start of initiating SGAs. This could be a vital step toward a successful treatment as the insight of youths into the details of the chosen treatment can play a significant role into treatment adherence and recovery.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 50 条
  • [41] Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics
    Fraguas, David
    Merchan-Naranjo, Jessica
    Laita, Paula
    Parellada, Mara
    Moreno, Dolores
    Ruiz-Sancho, Ana
    Cifuentes, Alicia
    Giraldez, Marisa
    Arango, Celso
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (07) : 1166 - 1175
  • [42] Metabolic side effects of second-generation antipsychotics in children and adolescents: A different story?
    Correll, CU
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (10) : 1331 - 1332
  • [43] Effect of second-generation Antipsychotics on employment and productivity in individuals with schizophrenia - An economic perspective
    Percudani, M
    Barbui, C
    Tansella, M
    PHARMACOECONOMICS, 2004, 22 (11) : 701 - 718
  • [44] Effect of Second-Generation Antipsychotics on Employment and Productivity in Individuals with SchizophreniaAn Economic Perspective
    Mauro Percudani
    Corrado Barbui
    Michele Tansella
    PharmacoEconomics, 2004, 22 : 701 - 718
  • [45] Gender differences in metabolic monitoring of second-generation antipsychotic prescription
    Verdoux, Helene
    Boulon, Sophie
    Cougnard, Audrey
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2008, 23 (06) : 471 - 474
  • [46] RATES AND PREDICTORS OF METABOLIC LABORATORY TEST MONITORING IN MOBILITY: A LARGE PRAGMATIC TRIAL OF YOUTH PRESCRIBED SECOND-GENERATION ANTIPSYCHOTICS
    Delbello, Melissa P.
    Welge, Jeffrey
    Blom, Thomas
    Klein, Christina
    Dyce, Brittany
    Higdon, Claudine
    Crystal, Stephen
    Patel, Nikesh
    Fornari, Victor
    Correll, Christoph U.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S248 - S249
  • [47] Monitoring of Recommended Metabolic Laboratory Parameters Among Medicaid Recipients on Second-Generation Antipsychotics in Federally Qualified Health Centers
    Uzal, Natalia E.
    Chavez, Benjamin
    Kosirog, Emily R.
    Billups, Sarah J.
    Saseen, Joseph J.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (02) : 160 - 165
  • [48] Metabolic monitoring in pediatric patients receiving second generation antipsychotics.
    Kauffman, Yardlee S.
    Botts, Sheila
    Gaughan, Kerri
    Delate, Thomas
    PHARMACOTHERAPY, 2013, 33 (10): : E226 - E226
  • [49] Impact of SGLT2 inhibitors on metabolic status in patients with psychiatric disorders undergoing treatment with second-generation antipsychotics (Review)
    Vasiliu, Octavian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (03)
  • [50] Understanding and managing cardiac side-effects of second-generation antipsychotics in the treatment of schizophrenia
    Sweeney, Mark
    Whiskey, Eromona
    Patel, Rishi K.
    Tracy, Derek K.
    Shergill, Sukhi S.
    Plymen, Carla M.
    BJPSYCH ADVANCES, 2020, 26 (01) : 26 - 40